PINK:NYE-Simplify Exchange Traded Funds - Simplify Health Care ETF (USD)

ETF | Others |

Last Closing

USD 32.9

Change

-0.13 (-0.39)%

Market Cap

USD 0.23B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.19 (+0.88%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.33 (+0.56%)

USD 34.45B
DFAC Dimensional U.S. Core Equity 2..

+0.29 (+0.87%)

USD 29.38B
DTB DTE Energy Company 2020 Series

+0.10 (+0.47%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

+0.04 (+0.08%)

USD 25.41B
SGOV iShares® 0-3 Month Treasury B..

+0.06 (+0.06%)

USD 25.27B
GBTC Grayscale Bitcoin Trust (BTC)

+1.11 (+2.39%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

+2.33 (+2.57%)

USD 12.53B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 11.98B
DFUV Dimensional US Marketwide Valu..

+0.34 (+0.84%)

USD 10.93B

ETFs Containing PINK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.34% 93% A 85% B
Dividend Return 0.22% 5% F 4% F
Total Return 20.56% 92% A 83% B
Trailing 12 Months  
Capital Gain 24.20% 87% B+ 81% B-
Dividend Return 0.64% 10% F 7% C-
Total Return 24.84% 85% B 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.80% 70% C- 53% F
Dividend Return 4.15% 66% D+ 46% F
Total Return 0.35% 19% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 8.46% 56% F 82% B
Risk Adjusted Return 49.00% 67% D+ 68% D+
Market Capitalization 0.23B 75% C 37% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.